PureTech Health plc Financial Ratios — PRTCY Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-32.44	-24.48	13.66	-17.99	89.27	0.89	-9.59	-8.87	-13.06	12.18	-30.2
Return on Assets (%)	- -	-23.94	-94.87	-19.81	-15.6	8.29	-11.17	60.91	0.62	-6.26	-6.11	-9.41	8.25	-19.3
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	110.06	1.14	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	-23.84	-4.05	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-76.2	-43.95	-867.05	-368.97	-1,706.19	-17,756.92	-635.39	-1,558.46	-1,433.05	-1,506	-9,464.4	-19,493.47	-3,154	-2,114.72
Operating Margin (%)	-76.2	-43.95	-867.05	-368.97	-1,706.19	-17,756.92	-635.39	-1,558.46	-1,433.05	-1,506	-9,464.4	-19,493.47	-3,154	-2,114.72
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-135.89	-75.65	-3,788.32	-476.16	-1,919.73	-10,878.62	-418.04	5,507.3	227.42	-590.77	-4,439.38	-4,813.73	550.96	-2,380.92
Profit Margin (%)	-139.36	-61.31	-2,069.73	-333.05	-1,126.06	4,072.62	-266.65	4,847.42	71.75	-606.85	-2,409.28	-8,759.6	1,240.09	-2,355.42
Net Income to Common Margin (%)	-139.36	-61.31	-2,069.73	-333.05	-1,126.06	4,072.62	-266.65	4,847.42	71.75	-606.85	-2,409.28	-8,759.6	1,240.09	-2,355.42
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	23.49	75.92	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	-1.09	-0.03	-0.09	- -	-0.09	-0.05	-1.1	0.04	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-32.44	-24.51	13.67	-18.18	89.24	0.89	-9.59	-8.87	-13.06	12.18	-30.2

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	4	7	5	7	8	12	39	77	53	47	25	22	20
ST Debt	1	4	7	5	7	7	12	4	30	9	12	7	8	8
LT Debt	- -	- -	- -	- -	- -	- -	- -	35	47	43	34	18	15	11
Total Debt/EBITDA	-0.24	-1.38	-0.4	-0.11	-0.09	-0.07	-0.12	-0.29	-0.64	-0.35	-0.24	-0.17	-0.16	-0.2
Net Debt/EBITDA	1.55	0.94	3.15	2.96	0.76	0.56	1.01	0.97	3.03	2.97	0.67	1.28	2.03	2.51
Total Debt/EBIT	-0.24	-1.38	-0.4	-0.11	-0.09	-0.07	-0.12	-0.29	-0.64	-0.35	-0.24	-0.17	-0.16	-0.2
Net Debt/EBIT	1.55	0.94	3.15	2.96	0.76	0.56	1.01	0.97	3.03	2.97	0.67	1.28	2.03	2.51
EBITDA to Interest Expense	-9.92	-8.41	-6.73	-52.27	-168.02	-163.95	-265.35	-51.21	-40.57	-31.88	-50.04	-10.84	-13.56	-2.15
EBITDA-CapEx/Interest Expense	-12.31	-10.01	-6.89	-57.79	-176.38	-167.03	-276.81	-55.95	-42.42	-33.08	-50.59	-10.86	-13.56	-2.15
EBIT to Interest Expense	-9.92	-8.41	-6.73	-52.27	-168.02	-163.95	-265.35	-51.21	-40.57	-31.88	-50.04	-10.84	-13.56	-2.15
Interest Expense	1	- -	3	1	- -	1	- -	3	3	5	4	13	10	46
Common Equity/Total Assets	16.13	-5.27	30.98	67.6	59.47	61.76	62.37	70.98	67.65	62.74	77.17	66.87	68.82	58.36
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	0.69	0.21	5.37	7.18	7.41	6.28	3.98	3.6	3.63
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	0.61	0.2	5.06	6.42	6.8	5.79	3.77	3.41	3.41
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	0.12	0.08	3.71	4.74	4.58	4.9	2.63	2.43	2.07
Total Debt/Equity (%)	-43.5	-53.06	-29.8	3.02	7.52	13.2	7.41	6.04	11.72	9.03	8.56	5.53	5.48	6.41
Total Debt/Capital (%)	-76.99	-113.03	-42.46	2.93	7	11.66	6.9	5.7	10.49	8.28	7.88	5.24	5.2	6.02
Total Debt/Total Assets (%)	7.6	25.4	9.78	1.52	2.33	2.31	2.8	4.18	7.74	5.58	6.67	3.65	3.71	3.66
Net Debt to Equity	280.14	36.28	235.97	-78.61	-60.61	-109.39	-62.91	-20.13	-55.48	-76.34	-24.13	-40.89	-67.79	-80.99
Net Debt/Capital (%)	73.69	26.62	70.24	-367.61	-153.84	1,257.6	-168.64	-23.49	-111.13	-260.5	-29.72	-64.06	-184.78	-340.08
EBITDA	-6	-3	-17	-44	-74	-115	-104	-135	-120	-150	-198	-146	-136	-99
EBITDA-CapEx	-7	-4	-18	-48	-78	-118	-109	-148	-125	-156	-200	-146	-136	-99
Operating Income (Loss)	-6	-3	-17	-44	-74	-115	-104	-135	-120	-150	-198	-146	-136	-99

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.56	0.4	0.67	1.95	1.38	0.69	0.94	1.17	2.23	2.06	3.61	6.37	8.87	5.99
Current Ratio	0.63	0.53	0.71	1.98	1.41	0.72	0.98	1.21	2.29	2.22	3.99	6.76	9.33	6.59
Quick Ratio	0.56	0.4	0.67	1.95	1.38	0.69	0.94	1.17	2.23	2.06	3.61	6.37	8.87	5.99
CFO/Avg Current Liab	- -	-0.4	-0.18	-0.23	-0.32	-0.37	-0.27	-0.48	-0.82	-0.78	-1.11	-1.43	-2.9	-1.94
Common Equity/Total Assets	16.13	-5.27	30.98	67.6	59.47	61.76	62.37	70.98	67.65	62.74	77.17	66.87	68.82	58.36
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	0.69	0.21	5.37	7.18	7.41	6.28	3.98	3.6	3.63
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	0.61	0.2	5.06	6.42	6.8	5.79	3.77	3.41	3.41
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	0.12	0.08	3.71	4.74	4.58	4.9	2.63	2.43	2.07
Total Debt/Equity (%)	-43.5	-53.06	-29.8	3.02	7.52	13.2	7.41	6.04	11.72	9.03	8.56	5.53	5.48	6.41
Total Debt/Capital (%)	-76.99	-113.03	-42.46	2.93	7	11.66	6.9	5.7	10.49	8.28	7.88	5.24	5.2	6.02
Total Debt/Total Assets (%)	7.6	25.4	9.78	1.52	2.33	2.31	2.8	4.18	7.74	5.58	6.67	3.65	3.71	3.66
CFO/Total Liabilities	-6.44	-35.39	-11.18	-17.58	-28.13	-31.65	-26.49	-33.76	-39.18	-43.74	-115.31	-44.93	-69.01	-37.17
CFO/CapEx	-1	-14.92	-25.1	-6.21	-15.79	-40.85	-16.21	-7.83	-24.3	-27.96	-82.17	-432.31	-12,215.36	-14,188.5
Altman's Z-Score	-4.09	-4.78	-2.74	-0.31	-1.23	-1.95	-1.3	-0.05	27.79	17.79	34.25	19.48	13.64	10.31

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	4.33	0.91	9.92	11.39	0.68	10.48	5.26	3.68	3.48	0.28	0.11	2.21	2.84
Days Sales Outstanding	- -	84.32	400.65	36.78	32.05	539.64	34.84	69.42	99.23	104.83	1,313.39	3,465.8	164.86	128.48
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	15,438	10,648	8,886	7,661	4,420	4,022
- Cash & Cash Equivalents	11	7	62	134	63	73	117	132	404	466	150	191	281	252
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	-6	-7	-45	-57	-85	-150	-109	-18	-16	-9	5	-6	-7	-6
+ Total Debt	1	4	7	5	7	8	12	39	77	53	47	25	22	20
Enterprise Value	-17	-12	-102	-365	-360	-331	-347	-141	15,094	10,226	8,588	7,353	4,068	3,758
Total Capital	-2	-4	-16	169	99	67	179	690	730	637	594	484	430	325
Total Debt/Capital (%)	-76.99	-113.03	-42.46	2.93	7	11.66	6.9	5.7	10.49	8.28	7.88	5.24	5.2	6.02
Total Debt / EV	-0.09	-0.36	-0.07	-0.01	-0.02	-0.02	-0.04	-0.28	0.01	0.01	0.01	- -	0.01	0.01
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	1,809.65	1,024.77	4,109.29	9,804.27	942.76	806.51
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	1,581	1,060	908	779	473	401
Diluted Enterprise Value	-16	-10	-100	-186	-141	-215	-213	-111	1,238	638	811	607	208	161
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	52.8	35.53	30.83	27.05	16.99	15.55
TTM Sales	8	7	2	12	4	1	16	9	8	10	2	1	4	5
TTM EBITDA	-6	-3	-17	-44	-74	-115	-104	-135	-120	-150	-198	-146	-136	-99
TTM Operating Income	-6	-3	-17	-44	-74	-115	-104	-135	-120	-150	-198	-146	-136	-99
TTM Cash Flow to Firm	-1	-8	-8	-28	-58	-88	-72	-96	-131	-153	-177	-81	-123	-40
TTM Free Cash Flow to Firm	1	-8	-8	-23	-54	-86	-68	-84	-126	-148	-175	-81	-123	-40

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	-12.51	-6.95	-5.14	-7.37	-3.52	-4.71
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-17	-12	-102	-365	-360	-331	-347	-141	15,094	10,226	8,588	7,353	4,068	3,758
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	33	35	18.15	17.08	18.19	13.3
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	1,809.65	1,024.77	4,109.29	9,804.27	942.76	806.51
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	257.69	- -	- -	- -	8.78	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	214.42	-24.06	-15.93	-11.05	11.44	-3.87
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	271.48	-31.19	-24.64	-16.19	16.17	-4.39
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	157.48	-16.56	-10.26	-7.18	8.65	-2.92
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	23.05	17.94	16.39	16.51	10.66	12.89
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	19.18	24.66	14.47	15.39	13.88	13.67
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	24.28	31.96	22.38	22.55	19.63	15.49
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	14.09	16.97	9.32	10.01	10.5	10.3
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	23.08	17.97	16.41	16.54	10.67	12.91
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	19.21	24.7	14.49	15.42	13.9	13.7
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	24.32	32.01	22.42	22.59	19.66	15.52
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	14.11	17	9.34	10.03	10.52	10.32
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	184.9	106.26	434.63	1,038.16	108.86	86
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	153.85	146.03	383.76	967.57	141.81	91.23
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	194.8	189.26	593.63	1,417.98	200.5	103.36
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	113	100.52	247.29	629.23	107.27	68.74
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	-11.7	-6.7	-5.08	-7.35	-3.5	-4.71
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	-9.73	-9.21	-4.49	-6.85	-4.55	-4.99
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	-12.33	-11.93	-6.94	-10.04	-6.44	-5.66
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	-7.15	-6.34	-2.89	-4.46	-3.44	-3.76
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	-10.41	-9.55	-4.54	-6.87	-4.58	-4.99
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	-13.18	-12.38	-7.02	-10.06	-6.48	-5.66
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	-7.65	-6.57	-2.93	-4.47	-3.47	-3.76
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	1,498.88	1,424.1	3,707.4	9,291.18	1,272.89	864.38
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	1,908.71	1,858.25	5,760.53	13,722.77	1,825.09	986.13
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	1,089.89	967.09	2,372.42	5,962.25	947.86	638.57
EV/EBITDA Average	2.62	3.26	5.75	4.26	1.91	1.86	2.05	0.82	-104.59	-94.56	-39.17	-47.66	-40.36	-40.87
EV/EBITDA High	2.62	3.26	5.75	4.26	1.91	1.86	2.05	0.82	-133.19	-123.39	-60.87	-70.4	-57.87	-46.63
EV/EBITDA Low	2.62	3.26	5.75	4.26	1.91	1.86	2.05	0.82	-76.05	-64.22	-25.07	-30.59	-30.05	-30.2
EV/EBIT Average	2.62	3.26	5.75	4.26	1.91	1.86	2.05	0.82	-104.59	-94.56	-39.17	-47.66	-40.36	-40.87
EV/EBIT High	2.62	3.26	5.75	4.26	1.91	1.86	2.05	0.82	-133.19	-123.39	-60.87	-70.4	-57.87	-46.63
EV/EBIT Low	2.62	3.26	5.75	4.26	1.91	1.86	2.05	0.82	-76.05	-64.22	-25.07	-30.59	-30.05	-30.2
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	54	37	31.9	28.18	18.46	16.64
High Price	- -	- -	- -	- -	- -	- -	- -	- -	56.89	65.9	43.57	38.49	34	20
Enterprise Value Average	-16	-10	-100	-186	-141	-215	-213	-111	12,502	14,211	7,748	6,968	5,493	4,027
Enterprise Value High	-16	-10	-100	-186	-141	-215	-213	-111	15,921	18,543	12,040	10,292	7,875	4,594
Enterprise Value Low	-16	-10	-100	-186	-141	-215	-213	-111	9,091	9,651	4,958	4,472	4,090	2,975

Shares Outstanding	227	227	227	226	233	237	282	285	286	288	279	272	239	242
Diluted Weighted Avg Shares	23	23	23	19	23	24	27	29	29	29	28	28	26	24
Basic Weighted Avg Shares	23	23	23	19	23	24	27	28	29	29	28	28	25	24
Revenue per Share	0.35	0.31	0.09	0.64	0.19	0.03	0.6	0.31	0.29	0.35	0.07	0.03	0.17	0.19
EBITDA per Share	-0.27	-0.14	-0.77	-2.36	-3.22	-4.9	-3.8	-4.78	-4.19	-5.24	-6.95	-5.29	-5.35	-4.09
Operating Income per Share	-0.27	-0.14	-0.77	-2.36	-3.22	-4.9	-3.8	-4.78	-4.19	-5.24	-6.95	-5.29	-5.35	-4.09
Basic EPS, GAAP	-0.49	-0.19	-1.83	-2.13	-2.13	1.12	-1.59	14.86	0.21	-2.11	-1.77	-2.38	2.1	-4.56
Basic EPS from Cont Ops	-0.5	-0.25	-3.34	-3.14	-3.56	-3.19	-2.58	12.92	0.16	-2.19	-1.3	-2.41	1.09	-4.57
Diluted EPS, GAAP	-0.49	-0.19	-1.83	-2.13	-2.13	1.11	-1.59	14.43	0.2	-2.11	-1.77	-2.38	2.09	-4.56
Diluted EPS from Cont Ops	-0.5	-0.25	-3.34	-3.14	-3.56	-3.14	-2.58	12.55	0.16	-2.19	-1.3	-2.41	1.09	-4.57
Dividend per Share	0.01	- -	- -	- -	- -	- -	0.04	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.06	-0.39	-0.46	-1.54	-2.53	-3.77	-2.66	-3.46	-4.62	-5.52	-6.28	-3.83	-5.28	-3.54
Free Cash Flow per Basic Share	-0.13	-0.41	-0.48	-1.79	-2.69	-3.86	-2.82	-3.91	-4.81	-5.72	-6.36	-3.84	-5.28	-3.54
Cash & Equivalents per Share	0.05	0.04	0.28	1.38	1.21	0.79	0.89	0.57	1.41	1.62	1.26	1.2	1.53	1.15
Book Value per Share	0.01	- -	0.1	0.98	0.76	0.88	0.98	2.34	2.34	2.06	1.95	1.71	1.73	1.29
Tangible Book Value per Share	- -	-0.02	0.08	0.96	0.75	0.87	0.96	2.34	2.34	2.06	1.94	1.7	1.73	1.29

PureTech Health plc

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)